Vascular endothelial growth factor and its receptors in control and diabetic rat eyes

Laboratory Investigation

Volumn 78, Issue 8, 1998, Pages 1017-1027

  Gilbert, Richard E ^a   Vranes, Dimitria ^a   Berka, Jennifer L ^a   Kelly, Darren J ^a   Cox, Alison ^a   Wu, Leonard L ^a   Stacker, Steven A ^b   Cooper, Mark E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETIC RETINOPATHY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; STREPTOZOCIN DIABETES; VASCULAR ENDOTHELIUM;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOKINES; MALE; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETINA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031871492     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Adamis AP, Miller JW, Banal MT, Damico DJ, Folkman J, Yeo TK, and Yeo KT (1994). Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthal 118:445-450.
2. Ahmed A, Dunk C, Kniss D, and Wilkes M (1997). Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 76:779-791.
3. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, and King GL (1994). Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487.
4. Akbarian A, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP, Potkin SG, Sandman CA, Bunney WE Jr, and Jones EG (1996). Selective alterations in gene expression for NDMA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 16:19-30.
5. Allen TJ, Cooper ME, O'Brien RC, Bach LA, Jackson B, and Jerums G (1990). Glomerular filtration rate in the streptozocin diabetic rat: The role of exchangeable sodium, vasoactive hormones and insulin therapy. Diabetes 38:1182-1190.
6. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, and Abrams GW (1997). Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38:36-47.
7. 33P. J Histochem Cytochem 41: 1767-1773.
8. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, and Nagy A (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
9. de Vries C, Escobedo J, Ueno H, Houck K, Ferrara N, and Williams L (1992). The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
10. Ferrara N (1995). Vascular endothelial growth factor: The trigger for neovascularization in the eye. Lab Invest 72:615-618.
11. Ferrara N and Davis-Smyth T (1997). The biology of vascular endothelial growth factor. Endocr Rev 18:4-25.
12. Fong GH, Rossant J, Gertsenstein M, and Breitman ML (1995). Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70.
13. Gilbert RE, Cox A, McNally PG, Dziadek M, Wu LL, Cooper ME, and Jerums G (1997). Increased epidermal growth factor expression in diabetes related kidney growth. Diabetologia 40:778-785.
14. Gilbert RE, McNally PG, Cox A, Dziadek M, Rumble J, Cooper ME, and Jerums G (1995). SPARC gene expression is reduced in early diabetes related kidney growth. Kidney Int 48:1216-1225.
15. Gin T, Joon TL, Panagiotopoulos S, Cooper ME, Taylor H, and Jerums G (1996). Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat. Invest Ophthalmol Vis Sci 37:281-289.
16. Gruden G, Thomas S, Burt D, Lane S, Chusney G, Sacks S, and Viberti G (1997). Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction. Proc Natl Acad Sci USA 94:12112-12116.
17. Hammes H, Martin S, Federlin K, Geisen K, and Brownlee M (1991). Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88:11555-11558.
18. Iruela-Arispe ML and Dvorak HF (1997). Angiogenesis: A dynamic balance of stimulators and inhibitors. Thromb Haemost 78:672-677.
19. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, and Adamis AP (1998). Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 101:1219-1224.
20. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, and Jain RK (1996). During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2:992-997.
21. Mendelsohn F, Dunbar M, Allen A, Chou S, Millan M, Aguilera G, and Catt K (1987). Localization of angioteinsin II receptors in rat and monkey kidney by in vitro autoradiography. Kidney Int Suppl 31:S40-S44.
22. Mulder H, Ahren B, and Sundler F (1996). Islet amyloid polypeptide (amylin) and insulin are differentially expressed in chronic diabetes induced by streptozotocin in rats. Diabetologia 39:649-657.
23. Murata T, Kakagawa K, Khalil A, Ishibashi T, Inomta H, and Sueshi K (1996). The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 74:819-825.
24. Pe'er J, Shweiki D, Itin A, Memo I, Gnessin H, and Keshet E (1995). Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 72:638-645.
25. Schmidt FH (1961). Enzymatic determination of glucose and fructose simultaneously. Klin Wochenschr 39:1244-1247.
26. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, and Dvorak HF (1993). Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12:303-324.
27. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, and Schuh AC (1995). Failure of bloodisland formation and vasculogenesis in flk-1-deficient mice. Nature 376:62-66.
28. Simon M, Grone HJ, Johren O, Kullmer J, Plate KH, Risau W, and Fuchs E (1995). Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240-F250.
29. Sone H, Kawakami Y, Okuda Y, Sekine Y, Honmura S, Matsuo K, Segawa T, Suzuki H, and Yamashita K (1997). Ocular vascular endothelial growth factor in diabetic rats are elevated before observable retinal proliferative changes. Diabetologia 40:726-730.
30. Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam B, Murray-McIntosh RP, and Cooper ME (1997). Advanced glycation end products and the receptor for advanced glycated end products co-localise in organs susceptible to diabetic microvascular injury: Immunohistochemical studies. Diabetologia 40:619-628.
31. Terman BI, Dougher VM, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, and Bohlen P (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187: 1579-1586.
32. Thieme H, Aiello LP, Takagi H, Ferrara N, and King GL (1995). Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 44:98-103.
33. Tilton RG, Pugliese G, Faller AM, LaRose LS, Province MA, and Williamson JR (1992). Interaction between hypertension and diabetes on vascular function and structure in rats. J Diabet Complications 6:187-196.
34. van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, and Isner JM (1997). Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95:1030-1037.
35. Wen Y, Edelman JL, Kang T, Zeng N, and Sachs G (1998). Two functional forms of vascular endothelial growth factor receptor-2/flk-1 mRNA are expressed in normal rat retina. J Biol Chem 273:2090-2097.
36. Williams B, Gallacher B, Patel H, and Orme C (1997). Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 46:1497-1503.
37. Williamson JR, Chang K, Tilton RG, Prater C, Jeffrey JR, Weigel C, Sherman WR, Eades DM, and Kilo C (1987). Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozotocin-induced diabetes. Diabetes 36:813-821.
38. Wookey PJ, Tikellis C, Du H-C, Qin H-F, Sexton PM, and Cooper ME (1996). Amylin binding in rat renal cortex, stimulation of adenyl cyclase and activation of plasma renin. Am J Physiol 270:F289-F294.
39. Wu L, Cox A, Roe C, Dziadek M, Cooper ME, and Gilbert RE (1997). Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the reninangiotensin system. Kidney Int 51:1553-1567.
40. Yamagishi S, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, Nomura M, and Yamamoto H (1997). Advanced glycation end products-driven angiogenesis in vitro. J Biol Chem 272:8723-8730.
41. Yang XJ and Cepko CL (1996). Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J Neurosci 16:6089-6099.
42. Yang W and de Bono DP (1997). A new role for vascular endothelial growth factor and fibroblast growth factors: Increasing endothelial resistance to oxidative stress. FEBS Lett 403:139-142.